Literature DB >> 1723049

C-terminal neuropeptide Y fragments are mast cell-dependent vasodepressor agents.

G H Shen1, L Grundemar, Z Zukowska-Grojec, R Håkanson, C Wahlestedt.   

Abstract

Neuropeptide Y (NPY) is a well-established vasopressor agent present in sympathetic perivascular nerves. Recently, it was found that high doses of the peptide cause a biphasic pressor-depressor response upon intravenous administration. We now report that C-terminal NPY fragments (NPY-(18-36) and NPY-(22-36] given intravenously to conscious or pithed (areflexive) male Sprague-Dawley rats mimic the depressor component of the NPY-(1-36) response while displaying very low pressor activity. Additionally, we have found that the depressor component is blocked by the histamine H1-antagonist, mepyramine. Since the fragment, NPY-(22-36), was equipotent with NPY in inducing histamine release from isolated peritoneal mast cells, we conclude that short C-terminal NPY fragments, like NPY itself, act on mast cells to initiate histamine-mediated cardiovascular actions. Such actions may conceivably be accounted for by the abundance of positively charged amino acid residues in the C-terminus. Moreover, these fragments have little affinity for vascular NPY receptors, as indicated by their poor ability to displace iodinated NPY or peptide YY (PYY) from specific binding sites on vascular smooth muscle cells derived from rat aorta. In conclusion, we propose that short C-terminal NPY fragments, which contain several positively charged amino acid residues, retain the ability of NPY to release histamine from rat mast cells while being essentially devoid of direct vascular motor activity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1723049     DOI: 10.1016/0014-2999(91)90849-l

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

Review 1.  Potential targets for intervention in radiation-induced heart disease.

Authors:  M Boerma; M Hauer-Jensen
Journal:  Curr Drug Targets       Date:  2010-11       Impact factor: 3.465

2.  Role of G-proteins in peptidergic activation of both human and rat cutaneous mast cells.

Authors:  B Emadi-Khiav; M Mousli; Y Landry
Journal:  Inflamm Res       Date:  1995-04       Impact factor: 4.575

3.  A quantitative ultrastructural investigation of tyrosine hydroxylase-immunoreactive axons in the hairy skin of the guinea pig.

Authors:  S Roth; W Kummer
Journal:  Anat Embryol (Berl)       Date:  1994-08

4.  The ability of neuropeptide Y to mediate responses in the murine cutaneous microvasculature: an analysis of the contribution of Y1 and Y2 receptors.

Authors:  Duc Quyen Chu; Helen M Cox; Soraia K P Costa; Herbert Herzog; Susan D Brain
Journal:  Br J Pharmacol       Date:  2003-08-26       Impact factor: 8.739

5.  Structure activity studies of mast cell activation and hypotension induced by neuropeptide Y (NPY), centrally truncated and C-terminal NPY analogues.

Authors:  L J Cross; A G Beck-Sickinger; M Bienert; W Gaida; G Jung; E Krause; M Ennis
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

6.  Isolation and characterization of a novel transcription factor that binds to and activates insulin control element-mediated expression.

Authors:  G L Robinson; S R Cordle; E Henderson; P A Weil; G Teitelman; R Stein
Journal:  Mol Cell Biol       Date:  1994-10       Impact factor: 4.272

7.  Preclinical research into basic mechanisms of radiation-induced heart disease.

Authors:  M Boerma; M Hauer-Jensen
Journal:  Cardiol Res Pract       Date:  2010-10-04       Impact factor: 1.866

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.